Arterial Spin-Labeled Perfusion of Pediatric Brain Tumors

References

1. 1.↵
   1. Ries L,
   2. Smith M,
   3. Gurney J

   1. Gurney JG,
   2. Smith MA,
   3. Bunin GR

   . CNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries L, Smith M, Gurney J , eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1965–1995. NIH Publication No. 99–4649. Bethesda, Maryland: National Cancer Institute SEER Program;1999:51–63
2. 2.↵
   1. Pollack IF

   . Brain tumors in children. N Engl J Med 1994;331:1500–07

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Sugahara T,
   2. Korogi Y,
   3. Kochi M,
   4. et al

   . Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–86

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Knopp EA,
   2. Cha S,
   3. Johnson G,
   4. et al

   . Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Sugahara T,
   2. Korogi Y,
   3. Kochi M,
   4. et al

   . Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 2001;22:1306–15

   Abstract/FREE Full Text
6. 6.↵
   1. Shin JH,
   2. Lee HK,
   3. Kwun BD,
   4. et al

   . Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002;179:783–89

   CrossRefPubMed
7. 7.↵
   1. Law M,
   2. Yang S,
   3. Wang H,
   4. et al

   . Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98

   Abstract/FREE Full Text
8. 8.↵
   1. Law M,
   2. Yang S,
   3. Babb JS,
   4. et al

   . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

   Abstract/FREE Full Text
9. 9.↵
   1. Aronen HJ,
   2. Gazit IE,
   3. Louis DN,
   4. et al

   . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Law M,
    2. Oh S,
    3. Babb JS,
    4. et al

    . Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging–prediction of patient clinical response. Radiology 2006;238:658–67

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Tzika AA,
    2. Astrakas LG,
    3. Zarifi MK,
    4. et al

    . Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer 2004;100:1246–56

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Cha S

    . Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients. Neuroimaging Clin N Am 2006;16:137–47, ix

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Thompson EM,
    2. Guillaume DJ,
    3. Dósa E,
    4. et al

    . Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors. J Neurooncol 2012;109:105–14

    CrossRefPubMed
14. 14.↵
    1. Löbel U,
    2. Sedlacik J,
    3. Reddick WE,
    4. et al

    . Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 2011;32:315–22

    Abstract/FREE Full Text
15. 15.↵
    1. Kimura H,
    2. Takeuchi H,
    3. Koshimoto Y,
    4. et al

    . Perfusion imaging of meningioma by using continuous arterial spin labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. AJNR Am J Neuroradiol 2006;27:85–93

    Abstract/FREE Full Text
16. 16.↵
    1. Warmuth C,
    2. Gunther M,
    3. Zimmer C

    . Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2003;228:523–32

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Järnum H,
    2. Steffensen EG,
    3. Knutsson L,
    4. et al

    . Perfusion MRI of brain tumors: a comparative study of pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging. Neuroradiology 2010;52:307–17

    CrossRefPubMedWeb of Science
18. 18.↵
    1. White CM,
    2. Pope WB,
    3. Zaw T,
    4. et al

    . Regional and voxel-wise comparisons of blood flow measurements between DSC magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors. J Neuroimaging 2014;24:23–30

    CrossRefPubMed
19. 19.↵
    1. van Westen D,
    2. Petersen ET,
    3. Wirestam R,
    4. et al

    . Correlation between arterial blood volume obtained by arterial spin labeling and cerebral blood volume in intracranial tumours. MAGMA 2011;24:211–23

    CrossRefPubMed
20. 20.↵
    1. Hirai T,
    2. Kitajima M,
    3. Nakmura H.,
    4. et al

    . Quantitative blood flow measurements in gliomas using arterial spin labeling at 3T: intermodality agreement and inter- and intraobserver reproducibility study. AJNR Am J Neuroradiol 2011;32:2073–79

    Abstract/FREE Full Text
21. 21.↵
    1. Dai W,
    2. Garcia D,
    3. Bazelaire C,
    4. et al

    . Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488–97

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Buxton RB,
    2. Frank LR,
    3. Wong EC,
    4. et al

    . A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40:383–96

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Noguchi T,
    2. Yshiura T,
    3. Hiwatashi A

    . Perfusion imaging of brain tumors using arterial spin labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol 2008;29:688–93

    Abstract/FREE Full Text
24. 24.↵
    1. Wolf RL,
    2. Wang J,
    3. Wang S,
    4. et al

    . Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J Magn Reson Imaging 2005;22:475–82

    CrossRefPubMed
25. 25.↵
    1. Parkes LM,
    2. Rashid W,
    3. Chard DT,
    4. et al

    . Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magn Reson Med 2004;51:736–43

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Ulmer S,
    2. Helle M,
    3. Jansen O,
    4. et al

    . Intraoperative dynamic susceptibility contrast weighed magnetic resonance imaging (iDSC-MRI)-technical considerations and feasibility. Neuroimage 2009;45:38–43

    CrossRefPubMed
27. 27.↵
    1. van Gelderen P,
    2. de Awart JA,
    3. Duyn JH

    . Pitfalls of MRI measurements of white matter perfusion based on arterial spin labeling. Magn Reson Med 2008;59:788–95

    CrossRefPubMed
28. 28.↵
    1. Ye FQ,
    2. Berman KF,
    3. Ellmore T,
    4. et al

    . H2 15O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med 2000;44:450–56

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Louis DN,
    2. Ohgaki H,
    3. Wiestler OD,
    4. et al.

    , eds. WHO Classification of Tumours of the Central Nervous System, Fourth Edition. Lyon, France: International Agency for Research on Cancer; 2007
30. 30.↵
    1. Kleihues P,
    2. Cavenee WK

    , eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon, France: International Agency for Research on Cancer; 2000
31. 31.↵
    1. Bredel M,
    2. Pollack IF,
    3. Hamilton RL,
    4. et al

    . Epidermal growth factor receptor (EGFR) expression and gene amplification in high grade non-brainstem gliomas of childhood. Clin Cancer Res 1999;5:1786–92

    Abstract/FREE Full Text
32. 32.↵
    1. Rickert CH,
    2. Strater R,
    3. Kaatsch P,
    4. et al

    . Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 2001;158:1525–32

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Suri V,
    2. Das P,
    3. Jain A,
    4. et al

    . Pediatric glioblastoma: a histopathological and molecular genetic study. Neuro Oncol 2009;11:274–80

    Abstract/FREE Full Text
34. 34.↵
    1. Wang J,
    2. Licht DJ,
    3. Jahng GH,
    4. et al

    . Pediatric perfusion imaging using pulsed arterial spin labeling. J Magn Reson Imaging 2003;18:404–13

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Deibler AR,
    2. Pollock JM,
    3. Kraft RA,
    4. et al

    . Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol 2008;29:1228–34

    Abstract/FREE Full Text
36. 36.↵
    1. Wolf RL,
    2. Detre JA

    . Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging. Neurotherapeutics 2007;4:346–59

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Kumabe T,
    2. Shimazu H,
    3. Sonoda Y,
    4. et al

    . Thallium-201 single-photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: three technical case reports. Neurosurgery 1999;45:183–187; discussion 187

    CrossRefPubMed
38. 38.↵
    1. Kleihues P,
    2. Cavenee WK

    1. Daumas-Duport C,
    2. Pietsch T,
    3. Lantos PL

    . Dysembryoplastic neuroepithelial tumour. In: Kleihues P, Cavenee WK , eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon, France: International Agency for Research on Cancer; 2000:103–106
39. 39.↵
    1. Abe M,
    2. Tabuchi K,
    3. Tsuji T,
    4. et al

    . Dysembryoplastic neuroepithelial tumor: report of three cases. Surg Neurol 1995;43:240–245

    CrossRefPubMed
40. 40.↵
    1. Kleihues P,
    2. Cavenee W

    1. Burger PC,
    2. Scheithauer BW,
    3. Paulus W,
    4. et al

    . Pilocytic astrocytoma. In: Kleihues P, Cavenee W , eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon, France: International Agency for Research on Cancer; 2000:45–51
41. 41.↵
    1. Birlik,
    2. Canda S,
    3. Ozer E

    . Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas. Neuropathol Appl Neurobiol 2006;32:532–38

    CrossRefPubMed
42. 42.↵
    1. Sie M,
    2. de Bont ES,
    3. Scherpen FJ,
    4. et al

    . Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma? Neuropathol Appl Neurobiol 2010;36:636–47

    CrossRefPubMed
43. 43.↵
    1. Bartels U,
    2. Hawkins C,
    3. Jing M,
    4. et al

    . Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas. J Neurosurg 2006;104:314–20

    PubMedWeb of Science
44. 44.↵
    Centers for Disease Control and Prevention. Data Collection of Primary Central Nervous System Tumors. National Program of Cancer Registries Training Materials. Atlanta, Georgia: Department of Health and Human Services, Centers for Disease Control and Prevention; 2004
45. 45.↵
    1. Rumboldt Z,
    2. Camacho DL,
    3. Lake D,
    4. et al

    . Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006;27:1362–69

    Abstract/FREE Full Text
46. 46.↵
    1. Yeom KW,
    2. Mobley BC,
    3. Lober RM,
    4. et al

    . Distinctive MRI features of pediatric medulloblastoma subtypes. AJR Am J Roentgenol 2013;200:895–903

    CrossRefPubMed
47. 47.↵
    1. Northcott PA,
    2. Korshunov A,
    3. Witt H,
    4. et al

    . Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011;29:1408–14

    Abstract/FREE Full Text
48. 48.↵
    1. Cho YJ,
    2. Tsherniak A,
    3. Tamayo P,
    4. et al

    . Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that derives poor clinical outcome. J Clin Oncol 2011;29:1424–30

    Abstract/FREE Full Text
49. 49.↵
    1. Wang J,
    2. Licht DJ

    . Pediatric perfusion MR imaging using arterial spin labeling. Neuroimaging Clin N Am 2006;16:149–67, ix

    CrossRefPubMedWeb of Science
50. 50.↵
    1. Toledo M,
    2. Munuera J,
    3. Salas-Puig X,
    4. et al

    . Localisation value of ictal arterial spin-labelled sequences in partial seizures. Epileptic Disord 2011;13:336–39

    PubMed